273 related articles for article (PubMed ID: 37046108)
1. The dynamic tumor-stromal crosstalk: implications of 'stromal-hot' tumors in the process of epithelial-mesenchymal transition in breast cancer.
Mavatkar AD; Naidu CM; Prabhu JS; Nair MG
Mol Biol Rep; 2023 Jun; 50(6):5379-5393. PubMed ID: 37046108
[TBL] [Abstract][Full Text] [Related]
2. Tumor-associated stromal cells as key contributors to the tumor microenvironment.
Bussard KM; Mutkus L; Stumpf K; Gomez-Manzano C; Marini FC
Breast Cancer Res; 2016 Aug; 18(1):84. PubMed ID: 27515302
[TBL] [Abstract][Full Text] [Related]
3. Adipocytes can induce epithelial-mesenchymal transition in breast cancer cells.
Lee Y; Jung WH; Koo JS
Breast Cancer Res Treat; 2015 Sep; 153(2):323-35. PubMed ID: 26285644
[TBL] [Abstract][Full Text] [Related]
4. Tumor-derived osteopontin drives the resident fibroblast to myofibroblast differentiation through Twist1 to promote breast cancer progression.
Butti R; Nimma R; Kundu G; Bulbule A; Kumar TVS; Gunasekaran VP; Tomar D; Kumar D; Mane A; Gill SS; Patil T; Weber GF; Kundu GC
Oncogene; 2021 Mar; 40(11):2002-2017. PubMed ID: 33603163
[TBL] [Abstract][Full Text] [Related]
5. The importance of microRNAs in the stroma-breast cancer cell interplay.
Susman S; Tomuleasa C; Fekete Z; Pilato B; Irimie A; Berindan-Neagoe I
Cancer Biomark; 2014; 14(2-3):137-44. PubMed ID: 24878814
[TBL] [Abstract][Full Text] [Related]
6. TWIST1-Induced miR-424 Reversibly Drives Mesenchymal Programming while Inhibiting Tumor Initiation.
Drasin DJ; Guarnieri AL; Neelakantan D; Kim J; Cabrera JH; Wang CA; Zaberezhnyy V; Gasparini P; Cascione L; Huebner K; Tan AC; Ford HL
Cancer Res; 2015 May; 75(9):1908-21. PubMed ID: 25716682
[TBL] [Abstract][Full Text] [Related]
7. Cancer-associated fibroblasts induce epithelial-mesenchymal transition of breast cancer cells through paracrine TGF-β signalling.
Yu Y; Xiao CH; Tan LD; Wang QS; Li XQ; Feng YM
Br J Cancer; 2014 Feb; 110(3):724-32. PubMed ID: 24335925
[TBL] [Abstract][Full Text] [Related]
8. A signature of epithelial-mesenchymal plasticity and stromal activation in primary tumor modulates late recurrence in breast cancer independent of disease subtype.
Cheng Q; Chang JT; Gwin WR; Zhu J; Ambs S; Geradts J; Lyerly HK
Breast Cancer Res; 2014 Jul; 16(4):407. PubMed ID: 25060555
[TBL] [Abstract][Full Text] [Related]
9. The Roles of Stroma-Derived Chemokine in Different Stages of Cancer Metastases.
Hussain S; Peng B; Cherian M; Song JW; Ahirwar DK; Ganju RK
Front Immunol; 2020; 11():598532. PubMed ID: 33414786
[TBL] [Abstract][Full Text] [Related]
10. SREBP1, targeted by miR-18a-5p, modulates epithelial-mesenchymal transition in breast cancer via forming a co-repressor complex with Snail and HDAC1/2.
Zhang N; Zhang H; Liu Y; Su P; Zhang J; Wang X; Sun M; Chen B; Zhao W; Wang L; Wang H; Moran MS; Haffty BG; Yang Q
Cell Death Differ; 2019 May; 26(5):843-859. PubMed ID: 29988076
[TBL] [Abstract][Full Text] [Related]
11. Emodin reduces Breast Cancer Lung Metastasis by suppressing Macrophage-induced Breast Cancer Cell Epithelial-mesenchymal transition and Cancer Stem Cell formation.
Liu Q; Hodge J; Wang J; Wang Y; Wang L; Singh U; Li Y; Yao Y; Wang D; Ai W; Nagarkatti P; Chen H; Xu P; Murphy EA; Fan D
Theranostics; 2020; 10(18):8365-8381. PubMed ID: 32724475
[TBL] [Abstract][Full Text] [Related]
12. Curcumin suppresses crosstalk between colon cancer stem cells and stromal fibroblasts in the tumor microenvironment: potential role of EMT.
Buhrmann C; Kraehe P; Lueders C; Shayan P; Goel A; Shakibaei M
PLoS One; 2014; 9(9):e107514. PubMed ID: 25238234
[TBL] [Abstract][Full Text] [Related]
13. Systematic analysis of metastasis-associated genes identifies miR-17-5p as a metastatic suppressor of basal-like breast cancer.
Fan M; Sethuraman A; Brown M; Sun W; Pfeffer LM
Breast Cancer Res Treat; 2014 Aug; 146(3):487-502. PubMed ID: 25001613
[TBL] [Abstract][Full Text] [Related]
14. Neoplastic and stromal cells contribute to an extracellular matrix gene expression profile defining a breast cancer subtype likely to progress.
Triulzi T; Casalini P; Sandri M; Ratti M; Carcangiu ML; Colombo MP; Balsari A; Ménard S; Orlandi R; Tagliabue E
PLoS One; 2013; 8(2):e56761. PubMed ID: 23441215
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-30a increases tight junction protein expression to suppress the epithelial-mesenchymal transition and metastasis by targeting Slug in breast cancer.
Chang CW; Yu JC; Hsieh YH; Yao CC; Chao JI; Chen PM; Hsieh HY; Hsiung CN; Chu HW; Shen CY; Cheng CW
Oncotarget; 2016 Mar; 7(13):16462-78. PubMed ID: 26918943
[TBL] [Abstract][Full Text] [Related]
16. MicroRNAs regulate the epithelial-mesenchymal transition and influence breast cancer invasion and metastasis.
Zhao M; Ang L; Huang J; Wang J
Tumour Biol; 2017 Feb; 39(2):1010428317691682. PubMed ID: 28222665
[TBL] [Abstract][Full Text] [Related]
17. MiR-155-mediated loss of C/EBPβ shifts the TGF-β response from growth inhibition to epithelial-mesenchymal transition, invasion and metastasis in breast cancer.
Johansson J; Berg T; Kurzejamska E; Pang MF; Tabor V; Jansson M; Roswall P; Pietras K; Sund M; Religa P; Fuxe J
Oncogene; 2013 Dec; 32(50):5614-24. PubMed ID: 23955085
[TBL] [Abstract][Full Text] [Related]
18. Activation of epithelial-mesenchymal transition process during breast cancer progression - the impact of molecular subtype and stromal composition.
Markiewicz A; Topa J; Popęda M; Szade J; Skokowski J; Wełnicka-Jaśkiewicz M; Żaczek A
Acta Biochim Pol; 2021 Aug; 68(3):385-392. PubMed ID: 34432400
[TBL] [Abstract][Full Text] [Related]
19. Fluid flow exposure promotes epithelial-to-mesenchymal transition and adhesion of breast cancer cells to endothelial cells.
Fuh KF; Shepherd RD; Withell JS; Kooistra BK; Rinker KD
Breast Cancer Res; 2021 Oct; 23(1):97. PubMed ID: 34641959
[TBL] [Abstract][Full Text] [Related]
20. Collagen-rich stroma in aggressive colon tumors induces mesenchymal gene expression and tumor cell invasion.
Vellinga TT; den Uil S; Rinkes IH; Marvin D; Ponsioen B; Alvarez-Varela A; Fatrai S; Scheele C; Zwijnenburg DA; Snippert H; Vermeulen L; Medema JP; Stockmann HB; Koster J; Fijneman RJ; de Rooij J; Kranenburg O
Oncogene; 2016 Oct; 35(40):5263-5271. PubMed ID: 26996663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
